Rodolfo Testa

708 total citations
34 papers, 617 citations indexed

About

Rodolfo Testa is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Urology. According to data from OpenAlex, Rodolfo Testa has authored 34 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 10 papers in Urology. Recurrent topics in Rodolfo Testa's work include Neuroscience and Neuropharmacology Research (12 papers), Receptor Mechanisms and Signaling (11 papers) and Urinary Bladder and Prostate Research (10 papers). Rodolfo Testa is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Receptor Mechanisms and Signaling (11 papers) and Urinary Bladder and Prostate Research (10 papers). Rodolfo Testa collaborates with scholars based in Italy, Germany and France. Rodolfo Testa's co-authors include Amedeo Leonardi, Elena Poggesi, Carlo Taddei, Patrizia Angelico, G Strada, Maurizio Sabbatini, Francesco Amenta, Lucia Vitaioli, C. Velasco and Carlo Melchiorre and has published in prestigious journals such as Pain, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Rodolfo Testa

34 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rodolfo Testa Italy 15 280 182 176 124 117 34 617
L. Guarneri Italy 14 192 0.7× 156 0.9× 248 1.4× 113 0.9× 122 1.0× 20 564
Patrizia Angelico Italy 15 210 0.8× 196 1.1× 266 1.5× 102 0.8× 127 1.1× 27 620
Steven A. Buckner United States 19 434 1.6× 154 0.8× 335 1.9× 110 0.9× 112 1.0× 57 986
David R. Blue United States 12 493 1.8× 311 1.7× 225 1.3× 179 1.4× 231 2.0× 18 837
Michael E. Brune United States 18 251 0.9× 83 0.5× 182 1.0× 155 1.3× 80 0.7× 41 746
A.V. Daza United States 12 253 0.9× 170 0.9× 188 1.1× 32 0.3× 73 0.6× 22 658
Masafumi Oshita Japan 15 667 2.4× 406 2.2× 195 1.1× 218 1.8× 364 3.1× 37 993
Lisbeth Nilvebrant Sweden 16 362 1.3× 248 1.4× 595 3.4× 78 0.6× 91 0.8× 29 1.1k
F Lefèvre-Borg France 18 398 1.4× 300 1.6× 57 0.3× 111 0.9× 193 1.6× 28 821
Bengt Sparf Sweden 13 291 1.0× 322 1.8× 344 2.0× 52 0.4× 80 0.7× 15 874

Countries citing papers authored by Rodolfo Testa

Since Specialization
Citations

This map shows the geographic impact of Rodolfo Testa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodolfo Testa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodolfo Testa more than expected).

Fields of papers citing papers by Rodolfo Testa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodolfo Testa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodolfo Testa. The network helps show where Rodolfo Testa may publish in the future.

Co-authorship network of co-authors of Rodolfo Testa

This figure shows the co-authorship network connecting the top 25 collaborators of Rodolfo Testa. A scholar is included among the top collaborators of Rodolfo Testa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodolfo Testa. Rodolfo Testa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angelico, Patrizia & Rodolfo Testa. (2010). TRPV4 as a target for bladder overactivity. F1000 Biology Reports. 2. 5 indexed citations
2.
Mennini, Tiziana & Rodolfo Testa. (2010). Are Descending Control Pathways of the Lower Urinary Tract and Pain Overlapping Systems?. Central Nervous System Agents in Medicinal Chemistry. 10(2). 113–147. 6 indexed citations
3.
Poggesi, Elena, Patrizia Angelico, P. Farina, et al.. (2008). Effect of selective antagonists of group I metabotropic glutamate receptors on the micturition reflex in rats. British Journal of Urology. 102(7). 890–898. 9 indexed citations
4.
Angelico, Patrizia, et al.. (2006). Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes. British Journal of Urology. 97(4). 837–846. 32 indexed citations
6.
Angelico, Patrizia, et al.. (2005). Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions. BMC Pharmacology. 5(1). 14–14. 21 indexed citations
7.
Tasler, Stefan, et al.. (2005). Non-competitive inhibitors of metabotropic glutamate receptor 5 (mGluR5). Bioorganic & Medicinal Chemistry Letters. 15(11). 2876–2880. 5 indexed citations
8.
Sagratini, Gianni, Michela Buccioni, Gabriella Marucci, et al.. (2004). (+)-Cyclazosin Derivatives as α1-Adrenoceptor Antagonists. Medicinal Chemistry Research. 13(3-4). 190–199. 6 indexed citations
9.
Eltze, Manfrid, Rainer Boer, Martin C. Michel, et al.. (2001). In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic α 1A - vs. α 1B - and α 1D -adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(6). 649–662. 27 indexed citations
10.
Velasco, C., et al.. (2001). Influence of pump compliance (peristaltic vs. infusion) on urodynamic measurement during cystometry in conscious rats. Journal of Pharmacological and Toxicological Methods. 45(3). 215–221. 6 indexed citations
12.
Sironi, Giorgio, Elena Poggesi, Amedeo Leonardi, et al.. (2000). Effects of intracavernous administration of selective antagonists of alpha(1)-adrenoceptor subtypes on erection in anesthetized rats and dogs.. PubMed. 292(3). 974–81. 20 indexed citations
13.
Hieble, J. Paul, et al.. (1999). Effects of α1-adrenoceptor antagonists on agonist and tilt-induced changes in blood pressure: relationships to uroselectivity. European Journal of Pharmacology. 373(1). 51–62. 10 indexed citations
14.
Testa, Rodolfo, et al.. (1997). Antagonism to noradrenaline-induced lethality in rats is related to affinity for the α1a-adrenoceptor subtype. Life Sciences. 61(22). 2177–2188. 1 indexed citations
15.
Giardinà, Dario, et al.. (1995). Receptor binding profile of cyclazosin, a new α1B-adrenoceptor antagonist. European Journal of Pharmacology. 287(1). 13–16. 33 indexed citations
16.
Testa, Rodolfo, et al.. (1995). The α1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Life Sciences. 57(13). PL159–PL163. 52 indexed citations
17.
Angelico, Patrizia, et al.. (1992). In vivo effects of different antispasmodic drugs on the rat bladder contractions induced by topically applied KC1. Journal of Pharmacological and Toxicological Methods. 27(1). 33–39. 4 indexed citations
18.
Testa, Rodolfo, R. Ceserani, Alessandro Vanasia, et al.. (1989). Profile of in Vitro Binding Affinities of Neuroleptics at Different Rat Brain Receptors: Cluster Analysis Comparison with Pharmacological and Clinical Profiles. Pharmaceutical Research. 6(7). 571–577. 16 indexed citations
19.
Ceserani, R., et al.. (1988). Receptor Binding Studies of the Flavone, REC 15/2053, and Other Bladder Spasmolytics. Pharmaceutical Research. 5(7). 430–433. 6 indexed citations
20.
Testa, Rodolfo, et al.. (1987). Effect of citalopram, amineptine, imipramine and nortriptyline on stress-induced (footshock) analgesia in rats. Pain. 29(2). 247–255. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026